Literature DB >> 20184487

Prediction of progression of definite necrotising enterocolitis to need for surgery or death in preterm neonates.

Ravisha Srinivasjois1, Elizabeth Nathan, Dorota Doherty, Sanjay Patole.   

Abstract

OBJECTIVE: To study the predictive abilities of laboratory parameters in the prediction of progression of definite necrotising enterocolitis (NEC) to need for surgery or death in preterm neonates.
METHODS: Retrospective analysis of data (January 2001-July 2006) on all preterm (gestation < 32 weeks) neonates with definite (Stage > or = II) NEC according to the Bell's staging in a regional referral centre. Group I included those who were medically managed (medical NEC) and Group II requiring surgery (surgical NEC). Serial changes in laboratory parameters (C-reactive protein, (CRP), platelet count, plasma glucose and lactate) within 24 h before and over 72 h after the diagnosis of NEC were correlated to progression to surgery or death.
RESULTS: CRP levels were significantly higher at 72 h in the surgical versus medical group. Plasma glucose and lactate levels were significantly higher when compared with the baseline levels at all time points for both groups. Receiver operator curve analysis (N = 30) indicated that significant rise in CRP [baseline to 72 h (area under the curve, AUC: 0.933, p = 0.001)] and in lactate levels [baseline to 48 h (AUC: 0.818, p = 0.047)] had a strong potential as a predictor for progression to surgery or death.
CONCLUSION: Serial changes in CRP and plasma lactate level may predict progression of definite NEC to surgery or death in preterm neonates.

Entities:  

Mesh:

Year:  2010        PMID: 20184487     DOI: 10.3109/14767050903551467

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  8 in total

1.  Predictive scores for mortality in full-term infants with necrotizing enterocolitis: experience of a tertiary hospital in Southwest China.

Authors:  Yu Zhang; Ji-Kun Ma; Hong Wei; Xiao-Wen Li; Lu-Quan Li; Jia-Lin Yu
Journal:  World J Pediatr       Date:  2015-12-18       Impact factor: 2.764

Review 2.  The Microbiome and Biomarkers for Necrotizing Enterocolitis: Are We Any Closer to Prediction?

Authors:  Brigida Rusconi; Misty Good; Barbara B Warner
Journal:  J Pediatr       Date:  2017-06-29       Impact factor: 4.406

3.  More than a gut feeling: predicting surgical necrotising enterocolitis.

Authors:  Jörn-Hendrik Weitkamp
Journal:  Gut       Date:  2013-09-24       Impact factor: 23.059

4.  Correlative Factors of the Deterioration of Necrotizing Enterocolitis in Small for Gestational Age Newborns.

Authors:  Lijuan Luo; Wenbin Dong; Lingping Zhang; Xuesong Zhai; Qingping Li; Xiaoping Lei
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

5.  Predictive factors for surgical treatment in preterm neonates with necrotizing enterocolitis: a multicenter case-control study.

Authors:  Sofia El Manouni El Hassani; Hendrik J Niemarkt; Joep P M Derikx; Daniel J C Berkhout; Andrea E Ballón; Margot de Graaf; Willem P de Boode; Veerle Cossey; Christian V Hulzebos; Anton H van Kaam; Boris W Kramer; Richard A van Lingen; Daniel C Vijlbrief; Mirjam M van Weissenbruch; Marc A Benninga; Nanne K H de Boer; Tim G J de Meij
Journal:  Eur J Pediatr       Date:  2020-12-02       Impact factor: 3.183

6.  What really causes necrotising enterocolitis?

Authors:  Thomas Peter Fox; Charles Godavitarne
Journal:  ISRN Gastroenterol       Date:  2012-12-17

7.  Bowel Perforation in Premature Infants with Necrotizing Enterocolitis: Risk Factors and Outcomes.

Authors:  Lingling Yu; Jianmei Tian; Xingli Zhao; Ping Cheng; Xiaoqian Chen; Yun Yu; Xiaochun Ding; Xueping Zhu; Zhihui Xiao
Journal:  Gastroenterol Res Pract       Date:  2016-06-08       Impact factor: 2.260

8.  Broad-spectrum Antibiotic Plus Metronidazole May Not Prevent the Deterioration of Necrotizing Enterocolitis From Stage II to III in Full-term and Near-term Infants: A Propensity Score-matched Cohort Study.

Authors:  Li-Juan Luo; Xin Li; Kai-Di Yang; Jiang-Yi Lu; Lu-Quan Li
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.